NO20014026L - Krampestillende derivater til behandling av betydelig skjelving - Google Patents

Krampestillende derivater til behandling av betydelig skjelving

Info

Publication number
NO20014026L
NO20014026L NO20014026A NO20014026A NO20014026L NO 20014026 L NO20014026 L NO 20014026L NO 20014026 A NO20014026 A NO 20014026A NO 20014026 A NO20014026 A NO 20014026A NO 20014026 L NO20014026 L NO 20014026L
Authority
NO
Norway
Prior art keywords
antispasmodic
derivatives
treatment
tremor
significant
Prior art date
Application number
NO20014026A
Other languages
English (en)
Other versions
NO20014026D0 (no
Inventor
Gregory S Connor
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of NO20014026D0 publication Critical patent/NO20014026D0/no
Publication of NO20014026L publication Critical patent/NO20014026L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
NO20014026A 1999-02-17 2001-08-17 Krampestillende derivater til behandling av betydelig skjelving NO20014026L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12041399P 1999-02-17 1999-02-17
PCT/US2000/003849 WO2000048549A2 (en) 1999-02-17 2000-02-15 Anticonvulsant derivatives useful in treating essential tremor

Publications (2)

Publication Number Publication Date
NO20014026D0 NO20014026D0 (no) 2001-08-17
NO20014026L true NO20014026L (no) 2001-10-17

Family

ID=22390119

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014026A NO20014026L (no) 1999-02-17 2001-08-17 Krampestillende derivater til behandling av betydelig skjelving

Country Status (24)

Country Link
US (1) US6214867B1 (no)
EP (1) EP1158950B1 (no)
JP (1) JP2002539088A (no)
KR (1) KR100664612B1 (no)
CN (1) CN1433306A (no)
AR (1) AR035986A1 (no)
AT (1) ATE316374T1 (no)
AU (1) AU779823B2 (no)
BR (1) BR0008791A (no)
CA (1) CA2362336C (no)
CZ (1) CZ295096B6 (no)
DE (1) DE60025705T2 (no)
DK (1) DK1158950T3 (no)
ES (1) ES2257288T3 (no)
HU (1) HUP0202634A3 (no)
IL (2) IL144943A0 (no)
MX (1) MXPA01008387A (no)
MY (1) MY129238A (no)
NO (1) NO20014026L (no)
NZ (1) NZ513724A (no)
TR (1) TR200103126T2 (no)
TW (1) TWI228413B (no)
WO (1) WO2000048549A2 (no)
ZA (1) ZA200107564B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002227052A1 (en) 2000-11-30 2002-06-11 University Of Florida Treatments for neurogenetic disorders, impulse control disorders, and wound healing
EP1429787A1 (en) * 2001-09-24 2004-06-23 Ortho-McNeil Pharmaceutical, Inc. Anticonvulsant derivatives useful for the treatment of restless limb syndrome and periodic limb movement disorder
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
US4981867A (en) 1989-12-08 1991-01-01 The Board Of Trustees Of The Leland Stanford Junior University Treatment of tremor using compounds that depress calcium currents in thalamic and other central nervous system neurons
IL103172A (en) * 1991-09-19 1997-01-10 Mcneilab Inc Preparation of chlorosulfate and sulfamate derivatives of 2, 3:4, 5-bis-o-(1-methylethylidene)-beta-d-fructopyranose and (1-methylcyclohexyl) methanol
US5735693A (en) * 1996-03-29 1998-04-07 Multi Lingua Ltd.. Method and device for learning a foreign language
UA65607C2 (uk) 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування

Also Published As

Publication number Publication date
NO20014026D0 (no) 2001-08-17
AU3364800A (en) 2000-09-04
CZ20013011A3 (cs) 2002-06-12
CN1433306A (zh) 2003-07-30
JP2002539088A (ja) 2002-11-19
MXPA01008387A (es) 2003-06-06
DK1158950T3 (da) 2006-04-24
DE60025705T2 (de) 2006-08-24
CA2362336A1 (en) 2000-08-24
AR035986A1 (es) 2004-08-04
IL144943A (en) 2006-08-20
ATE316374T1 (de) 2006-02-15
AU779823B2 (en) 2005-02-10
DE60025705D1 (de) 2006-04-13
HUP0202634A2 (hu) 2002-11-28
US6214867B1 (en) 2001-04-10
BR0008791A (pt) 2005-04-05
KR100664612B1 (ko) 2007-01-04
IL144943A0 (en) 2002-06-30
WO2000048549A3 (en) 2002-04-04
TR200103126T2 (tr) 2002-07-22
ZA200107564B (en) 2002-12-13
CZ295096B6 (cs) 2005-05-18
EP1158950A1 (en) 2001-12-05
MY129238A (en) 2007-03-30
HUP0202634A3 (en) 2005-02-28
NZ513724A (en) 2004-01-30
KR20010112272A (ko) 2001-12-20
WO2000048549A2 (en) 2000-08-24
EP1158950B1 (en) 2006-01-25
CA2362336C (en) 2005-04-12
TWI228413B (en) 2005-03-01
ES2257288T3 (es) 2006-08-01

Similar Documents

Publication Publication Date Title
NO20013369D0 (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
NO20013380L (no) 2-aminobenzoksazinonderivater for behandling av fedme
NO20005864D0 (no) Quinasoler til behandling av hjernesvulst
NO20022087D0 (no) Fremgangsmåte for behandling av diabetes
NO20021474L (no) Forbindelser for behandling av ischemi
NO20013381D0 (no) 2-oksybenzoksazinonderivater for behandling av fedme
NO20024775D0 (no) Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO20001870L (no) Ny fremgangsmÕte for behandling
NO990722D0 (no) FremgangsmÕte for behandling av hjertesvikt
NO20013507L (no) Blandinger for behandling av inflammatoriske reaksjoner
NO20015469D0 (no) Fremgangsmåte for behandling av petroleumsyrer
NO20024777L (no) Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte
NO20024776L (no) Hydroksyfenyl-piperazinyl-metyl-benzamid derivater til behandling av smerte
NO20020784L (no) Medikament for behandling av brudd
NO20003481D0 (no) FremgangsmÕte for behandling av COPD
NO20014026L (no) Krampestillende derivater til behandling av betydelig skjelving
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
NO993549D0 (no) Imino-aza-antracyklinonderivater til behandling av amyloidosis
NO20022956D0 (no) Fremgangsmåte for fremstilling av nitroguanidin
IS6020A (is) S-nítrósóþíól til meðferðar við blóðrásartruflunum
NO20020328D0 (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
NO20020327D0 (no) Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol
NO20012811D0 (no) Fremgangsmåte for fremstilling av p-klorfenyl-propanol- derivat
NO20022157D0 (no) Fremgangsmåte for behandling av medikamentavhengighet
NO20013044D0 (no) Fremgangsmåte for fremstilling av NG-substituerte deaza- adenosinderivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application